Clinical trial / 2008
A short-term oatmeal intervention lowered blood glucose and reduced required insulin dosage in patients with type 2 diabetes and severe insulin resistance.
Fourteen patients with uncontrolled type 2 diabetes and insulin resistance were evaluated before, after a 2-day oatmeal diet, and after a 4-week outpatient period. A hospital setting and diabetes-adapted diet alone improved glycemic control (mean blood glucose 158+/-47 mg/dl), and the 2-day oatmeal intervention further decreased mean blood glucose to 118+/-37 mg/dl (p<0.05). This was accompanied by a 42.5% reduction in daily insulin dosage (from 145+/-68.9 U/d to 83+/-34.2 U/d, p<0.001) and a 26.4% decrease in serum leptin levels (p<0.01). After 4 weeks of outpatient follow-up, the reduced insulin dosage was maintained (83+/-20.2 U/kg*d, p<0.01), mean blood glucose was 141+/-20.78 mg/dl, and adiponectin levels increased by 53.8% (p<0.05).
- Study type
- Uncontrolled prospective pilot trial
- Who was studied
- 14 patients with uncontrolled type 2 diabetes and severe insulin resistance
- What was measured
- Daily insulin requirement and mean blood glucose levels
THE PAPER
Clinical benefit of a short term dietary oatmeal intervention in patients with type 2 diabetes and severe insulin resistance: a pilot study.
Lammert A, Kratzsch J, Selhorst J, Humpert PM, Bierhaus A, Birck R, Kusterer K, Hammes HP. Exp Clin Endocrinol Diabetes, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.